PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VTRS vs. PFE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between VTRS and PFE is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

VTRS vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Viatris Inc. (VTRS) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

-15.00%-10.00%-5.00%0.00%5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
0.19%
-8.18%
VTRS
PFE

Key characteristics

Sharpe Ratio

VTRS:

0.09

PFE:

-0.04

Sortino Ratio

VTRS:

0.37

PFE:

0.11

Omega Ratio

VTRS:

1.04

PFE:

1.01

Calmar Ratio

VTRS:

0.07

PFE:

-0.02

Martin Ratio

VTRS:

0.21

PFE:

-0.10

Ulcer Index

VTRS:

12.44%

PFE:

8.69%

Daily Std Dev

VTRS:

28.96%

PFE:

22.94%

Max Drawdown

VTRS:

-52.28%

PFE:

-54.82%

Current Drawdown

VTRS:

-29.80%

PFE:

-50.82%

Fundamentals

Market Cap

VTRS:

$13.54B

PFE:

$149.04B

EPS

VTRS:

-$0.73

PFE:

$0.75

PEG Ratio

VTRS:

0.07

PFE:

0.20

Total Revenue (TTM)

VTRS:

$11.20B

PFE:

$45.86B

Gross Profit (TTM)

VTRS:

$4.46B

PFE:

$29.87B

EBITDA (TTM)

VTRS:

$2.58B

PFE:

$15.61B

Returns By Period

In the year-to-date period, VTRS achieves a -9.24% return, which is significantly lower than PFE's -0.87% return.


VTRS

YTD

-9.24%

1M

-9.74%

6M

-1.27%

1Y

3.20%

5Y*

N/A

10Y*

N/A

PFE

YTD

-0.87%

1M

-0.23%

6M

-8.50%

1Y

-1.32%

5Y*

-3.08%

10Y*

2.42%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VTRS vs. PFE — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VTRS
The Risk-Adjusted Performance Rank of VTRS is 4646
Overall Rank
The Sharpe Ratio Rank of VTRS is 4949
Sharpe Ratio Rank
The Sortino Ratio Rank of VTRS is 4242
Sortino Ratio Rank
The Omega Ratio Rank of VTRS is 4040
Omega Ratio Rank
The Calmar Ratio Rank of VTRS is 4949
Calmar Ratio Rank
The Martin Ratio Rank of VTRS is 4848
Martin Ratio Rank

PFE
The Risk-Adjusted Performance Rank of PFE is 4040
Overall Rank
The Sharpe Ratio Rank of PFE is 4343
Sharpe Ratio Rank
The Sortino Ratio Rank of PFE is 3535
Sortino Ratio Rank
The Omega Ratio Rank of PFE is 3434
Omega Ratio Rank
The Calmar Ratio Rank of PFE is 4444
Calmar Ratio Rank
The Martin Ratio Rank of PFE is 4343
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VTRS vs. PFE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Viatris Inc. (VTRS) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VTRS, currently valued at 0.09, compared to the broader market-2.000.002.004.000.09-0.04
The chart of Sortino ratio for VTRS, currently valued at 0.37, compared to the broader market-4.00-2.000.002.004.006.000.370.11
The chart of Omega ratio for VTRS, currently valued at 1.04, compared to the broader market0.501.001.502.001.041.01
The chart of Calmar ratio for VTRS, currently valued at 0.07, compared to the broader market0.002.004.006.000.07-0.02
The chart of Martin ratio for VTRS, currently valued at 0.21, compared to the broader market-10.000.0010.0020.0030.000.21-0.10
VTRS
PFE

The current VTRS Sharpe Ratio is 0.09, which is higher than the PFE Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of VTRS and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50AugustSeptemberOctoberNovemberDecember2025
0.09
-0.04
VTRS
PFE

Dividends

VTRS vs. PFE - Dividend Comparison

VTRS's dividend yield for the trailing twelve months is around 4.25%, less than PFE's 6.39% yield.


TTM20242023202220212020201920182017201620152014
VTRS
Viatris Inc.
4.25%3.86%4.43%4.31%2.44%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.39%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.54%3.70%3.48%3.34%

Drawdowns

VTRS vs. PFE - Drawdown Comparison

The maximum VTRS drawdown since its inception was -52.28%, roughly equal to the maximum PFE drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for VTRS and PFE. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%AugustSeptemberOctoberNovemberDecember2025
-29.80%
-50.82%
VTRS
PFE

Volatility

VTRS vs. PFE - Volatility Comparison

Viatris Inc. (VTRS) and Pfizer Inc. (PFE) have volatilities of 6.66% and 6.51%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%AugustSeptemberOctoberNovemberDecember2025
6.66%
6.51%
VTRS
PFE

Financials

VTRS vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Viatris Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab